PULMONOLOGY / CLINICAL RESEARCH
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Asthma and chronic obstructive pulmonary disease (COPD) are two common respiratory ailments with an overlapping pathogenesis.

Material and methods:
In this study, using a two-sample Mendelian randomization (MR) approach and analyzing publicly available genome-wide association study (GWAS) datasets, we explored the causal impact of asthma on the onset of COPD.

Results:
Using genetic instrumental variables associated with asthma (p < 5 × 10–8) and applying multiple MR methods (IVW, MR-Egger, and weighted median), we identified a significant causal relationship between asthma and COPD. The inverse variance weighted (IVW) method indicated that asthma increases the risk of developing COPD with an odds ratio (OR) of 1.35 (95% confidence interval [CI]: 1.12–1.58, p = 0.002). Additionally, multivariable MR analysis was performed to account for potential confounders, such as eosinophil count, smoking, and falls, which demonstrated that the association remains significant even after adjusting for these factors (OR = 1.29, 95% CI: 1.08–1.50, p = 0.004).

Conclusions:
This study provides robust evidence supporting the causal link between asthma and COPD, offering a more comprehensive understanding of their relationship.
REFERENCES (29)
1.
GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020; 8: 585-96.
 
2.
Long B, Rezaie SR. Evaluation and management of asthma and chronic obstructive pulmonary disease exacerbation in the emergency department. Emerg Med Clin North Am 2022; 40: 539-63.
 
3.
Forno E, Ortega VE, Celedón JC. Asthma and chronic obstructive pulmonary disease. Clin Chest Med 2023; 44: 519-30.
 
4.
Ayakannu R, Abdullah NA, Radhakrishnan AK, Raj VL, Liam CK. Relationship between various cytokines implicated in asthma. Hum Immunol 2019; 80: 755-63.
 
5.
Upadhyay P, Wu CW, Pham A, et al. Animal models and mechanisms of tobacco smoke-induced chronic obstructive pulmonary disease (COPD). J Toxicol Environ Health B Crit Rev 2023; 26: 275-305.
 
6.
Fouka E, Papaioannou AI, Hillas G, Steiropoulos P. Asthma-COPD Overlap Syndrome: Recent Insights and Unanswered Questions. J Pers Med 2022; 12: 708.
 
7.
Hikichi M, Hashimoto S, Gon Y. Asthma and COPD overlap pathophysiology of ACO. Allergol Int 2018; 67: 179-86.
 
8.
Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ 2021; 375: n2233.
 
9.
Demenais F, Margaritte-Jeannin P, Barnes KC, et al. Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks. Nat Genet 2018; 50: 42-53.
 
10.
Valette K, Li Z, Bon-Baret V, et al. Prioritization of candidate causal genes for asthma in susceptibility loci derived from UK Biobank. Commun Biol 2021; 4: 700.
 
11.
Sakaue S, Kanai M, Tanigawa Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet 2021; 53: 1415-24.
 
12.
Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 2023; 613: 508-18.
 
13.
Han Z, Hu H, Yang P, et al. White blood cell count and chronic obstructive pulmonary disease: a Mendelian randomization study. Comput Biol Med 2022; 151: 106187.
 
14.
Sakornsakolpat P, Prokopenko D, Maxime Lamontagne M, et al. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations. Nat Genet 2019; 51: 494-505.
 
15.
Rusk N. The UK Biobank. Nat Methods 2018; 15: 1001.
 
16.
Trajanoska K, Seppala LJ, Medibna-Gomez C, et al. Genetic basis of falling risk susceptibility in the UK Biobank Study. Commun Biol 2020; 3: 543.
 
17.
Oliveira CC, Annoni R, Lee AL, et al. Falls prevalence and risk factors in people with chronic obstructive pulmonary disease: a systematic review. Respir Med 2021; 176: 106284.
 
18.
Bowden J, Smith GD, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40: 304-14.
 
19.
Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife 2018; 7: e34408.
 
20.
Małujło-Balcerska E, Sipowicz K, Pietras T. Comparing chronic obstructive pulmonary disease and depressive disorder in terms of inflammation-related biomarkers. Arch Med Sci 2023; 19: 814-9.
 
21.
Lalas A, Nousias S, Kikidis D, et al. Substance deposition assessment in obstructed pulmonary system through numerical characterization of airflow and inhaled particles attributes. BMC Med Inform Decis Mak 2017; 17 (Suppl 3): 173.
 
22.
Park SY, Jung H, Kim JH, et al. Longitudinal analysis to better characterize asthma-COPD overlap syndrome: findings from an adult asthma cohort in Korea (COREA). Clin Exp Allergy 2019; 49: 603-14.
 
23.
Marron RM, Vega Sanchez ME. Asthma-COPD overlap syndrome. Chronic Obstr Pulm Dis 2019; 6: 200-2.
 
24.
Holtjer JCS, Bloemsma LD, Beijers RJHCG, et al. Identifying risk factors for COPD and adult-onset asthma: an umbrella review. Eur Respir Rev 2023; 32: 230009.
 
25.
Dey S, Eapen MS, Chia C, et al. Pathogenesis, clinical features of asthma COPD overlap, and therapeutic modalities. Am J Physiol Lung Cell Mol Physiol 2022; 322: L64-83.
 
26.
Van Eeckhoutte HP, Donovan C, Kim RY. RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD. Eur Respir J 2023; 61: 2201506.
 
27.
Varricchi G, Ferri S, Pepys J, et al. Biologics and airway remodeling in severe asthma. Allergy 2022; 77: 3538-52.
 
28.
Zhang Y, Xia R, Lv M, et al. Machine-learning algorithm-based prediction of diagnostic gene biomarkers related to immune infiltration in patients with chronic obstructive pulmonary disease. Front Immunol 2022; 13: 740513.
 
29.
Murdaca G, Tagliafico L, Page E, et al. Gender differences in the interplay between vitamin D and microbiota in allergic and autoimmune diseases. Biomedicines 2024; 12: 1023.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top